The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
Open accessAbstract
BACKGROUND: The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but data on long-term outcomes are limited. METHODS: For 4 years, we followed children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of RTS,S/AS01E vaccine (223 children) or rabies vaccine (224 controls). The end point was clinical malaria (temperature of ≥37.5°C and Plasmodium falciparum parasitemia density of >2500 parasites per cubic millimeter). Each child's exposure to malaria was estimated with the use of the distance-weighted local prevalence of malaria. RESULTS: Over a period of 4 years, 118 of 223 children who received the RTS,S/AS01E vaccine and 138 of 224 of the controls had at least 1 episode of clinical malaria. Vaccine efficacies in the intention-to-treat and per-protocol analyses were 29.9% (95% confidence interval [CI], 10.3 to 45.3; P=0.005) and 32.1% (95% CI, 11.6 to 47.8; P=0.004), respectively, calculated by Cox regression. Multiple episodes were common, with 551 and 618 malarial episodes in the RTS,S/AS01E and control groups, respectively; vaccine efficacies in the intention-to-treat and per-protocol analyses were 16.8% (95% CI, -8.6 to 36.3; P=0.18) and 24.3% (95% CI, 1.9 to 41.6; P=0.04), respectively, calculated by the Andersen-Gill extension of the Cox model. For every 100 vaccinated children, 65 cases of clinical malaria were averted. Vaccine efficacy declined over time (P=0.004) and with increasing exposure to malaria (P=0.001) in the per-protocol analysis. Vaccine efficacy was 43.6% (95% CI, 15.5 to 62.3) in the first year but was -0.4% (95% CI, -32.1 to 45.3) in the fourth year. Among children with a malaria-exposure index that was average or lower than average, the vaccine efficacy was 45.1% (95% CI, 11.3 to 66.0), but among children with a malaria-exposure index that was higher than average it was 15.9% (95% CI, -11.0 to 36.4). CONCLUSIONS: The efficacy of RTS,S/AS01E vaccine over the 4-year period was 16.8%. Efficacy declined over time and with increasing malaria exposure. (Funded by the PATH Malaria Vaccine Initiative and Wellcome Trust; ClinicalTrials.gov number, NCT00872963.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weltgesundheitsorganisation (2005) · Cited by 3,799
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Self-citationDirect and Indirect Effects in Vaccine Efficacy and Effectiveness
Halloran, M. E., Haber, M., Longini, I. M., & Struchiner, C. J. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115884 · Cited by 296
The decline in paediatric malaria admissions on the coast of Kenya
Okiro, E. A., Hay, S. I., Gikandi, P. W., Sharif, S. K., Noor, A. M., Peshu, N., Marsh, K., & Snow, R. W. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-151 · Cited by 254
Self-citationKreuels, B., Kobbe, R., Adjei, S., Kreuzberg, C., von Reden, C., Bäter, K., Klug, S., Busch, W., Adjei, O., & May, J. (2008) · The Journal of Infectious Diseases · doi:10.1086/524066 · Cited by 175
Olotu, A., Lusingu, J., Leach, A., Lievens, M., Vekemans, J., Msham, S., Lang, T., Gould, J., Dubois, M.-C., Jongert, E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70262-0 · Cited by 170
Self-citationLong‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
Sacarlal, J., Aíde, P., Aponte, J. J., Renom, M., Leach, A. J., Mandomando, I., Lievens, M., Bassat, Q., Lafuente, S., Macete, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600119 · Cited by 154
Self-citation3. Impact of culture and environmental changes on epidemiology and control of malaria and babesiosis
Greenwood, B. M. (1989) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(89)90599-3 · Cited by 151
Beier, J. C., Davis, J. R., Vaughan, J. A., et al. (1991) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.564 · Cited by 131
Plasmodium Falciparum-Infected Anopheles Stephensi Inconsistently Transmit Malaria to Humans
Rickman, L. S., Jones, T. R., Long, G. W., Paparello, S. F., Schneider, I., Paul, C. F., Beaudoin, R. L., & Hoffman, S. L. (1990) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1990.43.441 · Cited by 86
White, M. T., Griffin, J. T., DRAKELEY, C. J., & Ghani, A. C. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-82 · Cited by 58
Cheung, Y. B., Xu, Y., Tan, S. H., Cutts, F. T., & Milligan, P. J. (2009) · Statistics in Medicine · doi:10.1002/sim.3783 · Cited by 56
Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G. M., Ogada, E. A., DRAKELEY, C. J., Marsh, K., & Bejon, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032929 · Cited by 42
Self-citationGreenwood, B. M. (2005) · Clinical Infectious Diseases · doi:10.1086/429833 · Cited by 17
What is the efficacy of the RTS,S malaria vaccine?
Duncan, C. J. A., & Hill, A. V. S. (2011) · BMJ · doi:10.1136/bmj.d7728 · Cited by 13
Cited by
Immune checkpoint blockade in infectious diseases
Wykes, M. N., & Lewin, S. R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.112 · Cited by 570
The RTS, S. C. T. P. (. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001685 · Cited by 474
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Leach, A., Lievens, M., Kaslow, D. C., Njuguna, P., Marsh, K., & Bejon, P. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515257 · Cited by 421
Self-citationInnate sensing of malaria parasites
Gazzinelli, R. T., Kalantari, P., Fitzgerald, K. A., & Golenbock, D. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3742 · Cited by 355
White, M. T., Verity, R., Griffin, J. T., Asante, K. P., Owusu-Agyei, S., Greenwood, B., Drakeley, C., Gesase, S., Lusingu, J., Ansong, D., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00239-x · Cited by 354
Self-citation
Metadata
- Authors
- Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens, M., Leboulleux, D., Njuguna, P., Peshu, N., Marsh, K., & Bejon, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-21
- Volume
- 368
- Issue
- 12
- Pages
- 1111-1120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2094431581
- Cited by
- 270
- References
- 16
- FWCI
- 42.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.